Trial Profile
To investigate DPP-4 inhibitors type dependent effects on antifibrotic miRNA and biomarkers.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Feb 2018
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Linagliptin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 02 Feb 2018 Status changed from recruiting to completed.
- 15 Oct 2015 New trial record